ClinicalTrials.govpublic full text
The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis
ulcerative colitis, uc, vedolizumab, entyvio, inflammatory bowl disease, ibd, t-lymphocytes, regulatory, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 994728
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.